Noxopharm Ltd (NOX) — Financial Flexibility Index
Noxopharm Ltd (NOX) has a Financial Flexibility Index of -0.46x as of December 2025. Free cash flow of AU$-2.71 Million (operating CF AU$-2.71 Million minus capex AU$0.00) represents 0% of total liabilities (AU$5.88 Million). Also explore NOX net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Noxopharm Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Noxopharm Ltd across 10 annual periods. Check Noxopharm Ltd (NOX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Noxopharm Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Noxopharm Ltd. For the full company profile including market capitalisation, see Noxopharm Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.50x | AU$-5.82 Million | AU$-5.82 Million | AU$3.89 Million | ▼ -181.9% |
| 2024 | -0.53x | AU$-684.31K | AU$-684.31K | AU$1.29 Million | ▲ +94.9% |
| 2023 | -10.37x | AU$-10.95 Million | AU$-10.95 Million | AU$1.06 Million | ▼ -87.0% |
| 2022 | -5.55x | AU$-13.73 Million | AU$-13.73 Million | AU$2.48 Million | ▼ -343.6% |
| 2021 | -1.25x | AU$-8.85 Million | AU$-8.85 Million | AU$7.08 Million | ▲ +19.2% |
| 2020 | -1.55x | AU$-11.13 Million | AU$-11.14 Million | AU$7.19 Million | ▲ +8.9% |
| 2019 | -1.70x | AU$-9.77 Million | AU$-9.78 Million | AU$5.75 Million | ▲ +14.7% |
| 2018 | -1.99x | AU$-8.76 Million | AU$-9.08 Million | AU$4.40 Million | ▲ +74.7% |
| 2017 | -7.86x | AU$-2.84 Million | AU$-2.92 Million | AU$361.04K | ▼ -288.5% |
| 2016 | -2.02x | AU$-529.79K | AU$-549.72K | AU$261.72K | — |